EORTC QLQ C30 ESPAOL PDF

Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican. Conclusiones: el EORTC QLQ-C30 (versión ) se ha mostrado como un Spanish. EORTC QLQ-C RESULTS: Multitrait scaling analysis showed that most. The EORTC QLQ-C30 (in all versions), and the modules which supplement it, are Requests for permission to use the EORTC QLQ-C30 or to reproduce or.

Author: Zulkis Mezikora
Country: Greece
Language: English (Spanish)
Genre: Life
Published (Last): 1 May 2004
Pages: 166
PDF File Size: 16.62 Mb
ePub File Size: 18.64 Mb
ISBN: 189-5-27165-659-6
Downloads: 32399
Price: Free* [*Free Regsitration Required]
Uploader: Zushicage

Multitrait scaling analysis Most items exceeded the 0.

Results Patients’ characteristics and compliance patients from a total of that were addressed filled in the first questionnaire, did the second one and answered the third one. A consecutive sample of prostate cancer patients was included.

Evaluation of chemotherapeutic agents; ; Colombia University, New York, Item discriminant validity was successful in all analyses except in item 5 higher correlation with SF than with its own scaleitem 10 higher correlation with PF in the first measurement, and in the second assessment, item 20 higher correlations with EF and SF.

One of the major tasks of this group is the development of questionnaires for the assessment of QL in clinical trials.

New studies with other tumors could have a confirmatory value. These interscale correlations and known group analyses were in line with our previous and other studies 1, Patients’ characteristics and compliance patients from a total of that were addressed filled in the first questionnaire, did the second one and answered the third one. Interscale correlations indicated that the areas were related but represent different QL dimensions.

Most scales fulfilled the reliability criteria, except CF and NV.

EORTC Quality of Life website | EORTC Quality of Life Group website : EORTC – Quality of Life

Levels of compliance were high, with little missing data, indicating the instrument was well accepted. These instruments can also be used in clinical practice. CF had also shown low reliability scores in the validation studies we carried out with version 1. Validation study for spanish prostate sspaol patients. In SL, we could consider there has been an emotional adaptation to the disease and treatment. Patients completed the QLQ-C30 on the first and last day of radiotherapy, and one month and a half after the end of this particular treatment.

  C557 TRANSISTOR PDF

This sample consisted of eortv with localized disease T1-T3 N0 M0 who started radiotherapy with radical intention combined or not with hormotherapy at the Radiotherapeutic Oncology Department of the Hospital of Navarre. Acknowledgements This study eogtc received the support of a grant from the Health Department of the Gobierno de Navarra. Support Care Cancer; 7: These three analyses were performed at the first and second assessments.

Known group comparison analysis was performed by means of the Mann-Whitney U tests. In the validation study of version 3. Materials and methods Participants A consecutive sample of prostate cancer patients was included.

Validation study for Spain with head and neck cancer patients”. The highest correlations were between FA and PF – 0. The aims of this study are to determine the psychometric properties of the QLQ-C30 version 3. The comparisons between the different measurements were satisfactory as they had clinical significance. Patients espapl the QLQ-C30 version 3. These results showed the QLQ-C30 is highly sensitivity to changes. Interscale correlation coefficients were espaop higher in the second measurement.

Changes in functioning and symptom areas appeared throughout the different measurements, which were in line with the treatment process. Interscale correlations were calculated to study discriminant validity Two-tail analysis. Performance status – KPS was assessed by the physician at different time-points using the Karnofsky scale 8.

Multitrait scaling analysis showed that most item-scale correlation coefficients met the standards of convergent and discriminant validity. There was also a significant improvement between the second and third measurements, and between the first and the third in SL. Psychometric evaluation of the structure, reliability and qq was made. Items in the CF had not a much related content, which may have influenced the multitrait and reliability analyses.

  ASTM E2412 PDF

Internal consistence reliability estimates of the QLQ-C30 scales were above the 0.

The standard deviation of Esppaol in the two measurements has been low, which may have affected their Alpha coefficient.

A sample of prostate cancer patients prospectively filled in the questionnaire three times: Se han dado pocas excepciones, principalmente en la escala CF.

There was a problem providing the content you requested

Quality of Life QL assessment plays a key role in the evaluation and treatment of cancer patients nowadays. Responsiveness to change There was a significant worsening of the condition between the first and the second measurements in five areas PF, PA, CO, DI, FAa significant improvement between the second and third measurements, with no significant differences between the first and third questionnaires.

This QL group has created a combined assessment system composed of a generic core questionnaire, EORTC QLQ-C30, which evaluates issues common to different cancer sites and treatments, and a range of supplementary modules designed to assess specific issues, according to type of treatment or disease site, or to dimensions like fatigue.

Group comparison analyses showed better QL in patients with higher Performance Status. These studies are quite useful for professionals as, among other reasons, they offer an estimate of the QL values that could be expected in each country for different groups of patients, and also, because they explore if the QLQ-C30 has a good psychometric functioning when used with specific disease sites and stages.